Expression data from WT and ISG15 KO HaCaT cells stimulated with interferon-a and treated with combination treatment of Ruxolitinib, TGFb and Doxycycline

Analysis of gene expression in WT and ISG15 KO HaCaT cells, stimulated with IFNa and treated with ruxolitinib (RUX), transforming growth factor beta (TGFb) and doxycycline (DOXY) to investigate the effects of treatments on transcriptional response in the cells. WT and ISG15 KO HaCaT cells were stimulated with interferon-a for 8 hours. Cells were then treated with ruxolitinib (RUX), transforming growth factor beta (TGFb) and doxycycline (DOXY) for 16 hours. RNA was extracted, and subjected to transcriptome profiling array Clariom™ S Assay, human.